Presidential Plenary Session at #ACG2023- @MRegueiroMD showing results that IBD patients treated with biologics or oral small molecules do not have an increased risk of MACE or VTE events. In fact those on biologics had a lower risk of such events. @MoAlkhayyat @KAlsabb
Coming soon: India's very first #IBD Walk on #WorldIBDDay Fri, May 19th hosted by @YashodaHospital in collaboration w/ #SAIA!
Patients & caregivers: Come join us & help break the silence & create awareness in #India for #Crohns & #ulcerativecolitis!
Registration info below!
SAIA's inaugural CME event at #DDW is almost here!
Meet our stellar panel of patient advocates & clinicians from around the 🌏!
Join us on May 6th as we discuss strategies to enhance #SouthAsianIBD care!
Register to attend in-person/virtually here: https://t.co/Fu5ueupZxd
Thank you to the @AmJGastro for accepting our work showing that:
EHR burden 😓 is real ☑️
IBD and hepatology GI specialists spend ⬆️⬆️ time ⏱️ outside regular work hours on 💻 (pajama time 😴 💤✨🥱)
@AmanBaliMD@FarrayeIBD@ibdgijami@MayoClinicGIHep
https://t.co/KidT2tBlVA
Cardiovascular disease in IBD. Can we unravel the mechanistic link? Prospective and mechanistic studies will help understand the risk factors and role of medications? @paraj_patel@edwardloftus2 @marilylandibddoc @Sadeer_AlKindi@virani_md@IBDMD https://t.co/HI2CNzbq3s